![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
0
Listed Suppliers
0
USA (Orange Book)
0
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
https://www.globenewswire.com/news-release/2024/06/05/2894098/23024/en/Intercept-Presents-New-Data-on-the-Results-of-OCA-Bezafibrate-Combination-Therapy-in-PBC-After-Six-Months-of-Treatment-in-Late-Breaking-Poster-Presentation-at-EASL-Congress-2024.html
https://www.globenewswire.com/news-release/2024/05/18/2884546/23024/en/Intercept-Presents-New-Data-Demonstrating-the-Impact-of-OCA-Bezafibrate-Combination-Therapy-on-ALP-and-Metabolic-Outcomes-After-Six-Months-of-Treatment-at-Digestive-Disease-Week-20.html
https://www.globenewswire.com//news-release/2023/11/13/2779021/23024/en/Intercept-Announces-New-Phase-2-Data-Showing-Significant-Impact-of-OCA-Bezafibrate-Combination-on-Normalization-of-Multiple-Key-Biomarkers-of-PBC-Induced-Liver-Damage-at-AASLD-The-.html
https://www.globenewswire.com/news-release/2023/06/23/2693415/23024/en/Intercept-Presents-New-Data-Showing-Significant-Impact-of-OCA-bezafibrate-Combination-on-Normalization-of-Multiple-Biomarkers-of-PBC-Induced-Liver-Damage.html
https://www.globenewswire.com/news-release/2023/06/07/2683624/23024/en/Intercept-Announces-New-Data-Showing-Potential-of-Fixed-Dose-Combination-of-OCA-and-Bezafibrate-to-Normalize-Multiple-Biomarkers-in-PBC-to-be-Featured-in-Podium-Presentation-at-EAS.html
https://www.globenewswire.com/news-release/2022/05/11/2440783/23024/en/Intercept-Announces-First-Patient-Dosed-in-Phase-2-Study-of-OCA-and-Bezafibrate-for-the-Treatment-of-Primary-Biliary-Cholangitis.html
https://www.clinicaltrialsarena.com/comment/intercepts-phase-ii-ready-ocaliva-bezafibrate-has-mixed-experts-views-in-primary-biliary-cholangitis/
http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/2015/anvisa+suspende+empresa+sinbiotik+por+irregularidades